Page 411 - 16Neonatal Jaundice_compressed
P. 411

Neonatal jaundice


 Bibliographic   Study Type &   Number of   Intervention & Comparison   Dichotomous outcomes   Continuous Outcomes
 Information   Evidence Level   Patients/Characteristics   (E:C)   (Mean:SD: N)
 coverings.
 Author:   Methodology:   N: 88   Group 1:   ET:   Mean duration of phototherapy
 Martins B   RCT      Conventional Phototherapy   Group 1: 0/44   Group 1: 63.8 ± 37 hours
       Inclusion:      Group 2: 0/44
 Year:   Blinding:   Need for phototherapy   Group 2:      Group 2: 36.8 ± 21 hours
 2007   Not reported   according to birthweight   LED phototherapy   Erythema:
             Group 1: 0/44   TSB levels – change
 Country:   Randomisation:   Exclusion:   Conventional phototherapy consisted of  Group 2: 0/44   24 hours
 Brazil   Not reported   Direct bilirubin   a single quartz-halogen lamp, with a      Group 1: -22 ± 25 micromol/litre
       > 34 micromol/litre   dichroic reflector, positioned 50cm from  Treatment failure:
 158
 ID:     Evidence level:   Haemolytic jaundice,   the baby and illuminating a circle of   Group 1: 0/44   Group 2: -50 ± 26
 1 -   Ecchymosis,   18cm diameter.   Group 2: 0/44   micromol/litre
     Malformations,   Mean irradiance was
 2
 Congenital infection   21 ± 6microW/cm /nm

 Demographics:   LED phototherapy consisted of the
 Gender (M/F):58/30   Super LED system positioned 30cm
 Mean GA: 33.6 ± 1.9 weeks   from the patient and illuminating an
 Mean BW: 1998 ± 541 gms   elliptical area of 38cm x 27cm diameter.
 Age at entry to study   Mean irradiance was
 2
 68.1 ± 25.5 hours   37 ± 9microW/cm /nm
 Mean TSB:     Phototherapy discontinued when TSB
 179 ± 38 micromol/litre   levels decreased 30% from original
 levels

 Treatment was considered to have failed
 if TSB continued to rise and reached a
 level 30% below TSB levels required
 for exchange transfusion.

 Author: Ebbesen F   Methodology:   N: 141   Group 1:   ET:   Mean change in TSB:
    RCT      Blue phototherapy   Group 1: 0/69   Group 1: -78 ± 31 micromol/litre
 Year:      Inclusion:      Group 2: 0/72
 2007   Blinding:   Preterm infants (28 –   Group 2:      Group 2: -92 ± 31 micromol/litre
    Not reported   36.6 weeks),   Turquoise phototherapy
 Country:      Age > 24 hours,
 Denmark   Randomisation:   No previous phototherapy,
    Not stated but sealed  Non-haemolytic   Treatment duration was fixed (24 hours)
 160
 ID:     envelopes used   hyperbilirubinaemia
       Phototherapy consisted of either 8 blue
 Evidence level:   Exclusion:   fluorescent lamps (20 W, 60 x 3.7cm)
 1 +   Not reported   41 cm above the baby or 8 turquoise
 fluorescent lamps (18 W, 60 x 2.6cm)


 Demographics:   41 cm above the baby. Distance from
 Gender (M/F): 80/61   baby was different to ensure irradiance
 was identical in both groups
 278
   406   407   408   409   410   411   412   413   414   415   416